Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Sean Brynjelsen

CEO, President at Eton Pharmaceuticals, Inc. (ETON)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $9.9M

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC ETONEton Pharmaceuticals, Inc. Sell 8,9781,052,216 held (−1%) $62.65 $562K -11.9%
Aug 20SEC ETONEton Pharmaceuticals, Inc. Sell 47,3071,004,909 held (−4%) $60.17 $2.8M -8.2%
Aug 20SEC ETONEton Pharmaceuticals, Inc. Sell 36,373968,536 held (−4%) $61.11 $2.2M -9.7%
Aug 20SEC ETONEton Pharmaceuticals, Inc. Sell 7,342961,194 held (−1%) $62.12 $456K -11.1%
May 29SEC ETONEton Pharmaceuticals, Inc. Sell 119,852833,842 held (−13%) $31.88 $3.8M +73.2%
May 29SEC ETONEton Pharmaceuticals, Inc. Sell 148833,694 held (−0%) $32.67 $5K +69.0%